Beurs gesloten -
Japan Exchange
08:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4.335
JPY
|
+0,65%
|
|
+3,09%
|
-13,23%
|
Fiscaal tijdperk: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
542.875
|
571.160
|
554.319
|
561.052
|
392.668
|
291.974
|
-
|
-
|
Bedrijfswaarde
1 |
500.737
|
524.046
|
493.520
|
503.199
|
323.731
|
217.677
|
199.487
|
180.500
|
K/w-verhouding
|
33,3
x
|
33,9
x
|
26,8
x
|
22,5
x
|
17,2
x
|
10,7
x
|
10,6
x
|
9,46
x
|
Dividendrendement
|
0,87%
|
1,01%
|
1,2%
|
1,32%
|
1,96%
|
2,87%
|
3,08%
|
3,36%
|
Marktkapitalisatie/omzet
|
4,73
x
|
4,9
x
|
4,55
x
|
4,08
x
|
2,72
x
|
1,96
x
|
1,9
x
|
1,82
x
|
Bedrijfswaarde/omzet
|
4,37
x
|
4,49
x
|
4,05
x
|
3,66
x
|
2,25
x
|
1,46
x
|
1,3
x
|
1,12
x
|
Bedrijfswaarde/EBITDA
|
20,8
x
|
20,8
x
|
16,6
x
|
16,1
x
|
9,23
x
|
5,33
x
|
4,84
x
|
4,04
x
|
Bedrijfswaarde/FCF
|
35,6
x
|
51,2
x
|
26,2
x
|
52,1
x
|
37,9
x
|
9,19
x
|
8,81
x
|
7,67
x
|
FCF Yield
|
2,81%
|
1,95%
|
3,81%
|
1,92%
|
2,64%
|
10,9%
|
11,4%
|
13%
|
Price to Book
|
4,02
x
|
3,93
x
|
3,42
x
|
3,11
x
|
2,01
x
|
1,36
x
|
1,25
x
|
1,14
x
|
Aantal aandelen (in duizenden)
|
67.354
|
67.354
|
67.353
|
67.353
|
67.353
|
67.353
|
-
|
-
|
Referentieprijs
2 |
8.060
|
8.480
|
8.230
|
8.330
|
5.830
|
4.335
|
4.335
|
4.335
|
Datum van publicatie
|
13-05-19
|
13-05-20
|
14-05-21
|
11-05-22
|
11-05-23
|
-
|
-
|
-
|
Fiscaal tijdperk: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
114.716
|
116.637
|
121.885
|
137.484
|
144.175
|
149.208
|
153.400
|
160.795
|
EBITDA
1 |
24.062
|
25.136
|
29.684
|
31.232
|
35.090
|
40.872
|
41.221
|
44.726
|
Bedrijfsresultaat (EBIT)
1 |
20.644
|
21.668
|
26.134
|
32.948
|
30.049
|
35.213
|
36.027
|
40.459
|
Operationele Marge
|
18%
|
18,58%
|
21,44%
|
23,96%
|
20,84%
|
23,6%
|
23,49%
|
25,16%
|
Resultaat voor belastingen (EBT)
1 |
21.540
|
22.442
|
28.759
|
33.301
|
30.489
|
35.667
|
36.434
|
40.866
|
Nettowinst (verlies)
1 |
16.302
|
16.866
|
20.702
|
24.986
|
22.812
|
27.383
|
27.626
|
31.046
|
Nettomarge
|
14,21%
|
14,46%
|
16,98%
|
18,17%
|
15,82%
|
18,35%
|
18,01%
|
19,31%
|
WPA
2 |
242,0
|
250,4
|
307,4
|
371,0
|
338,7
|
404,3
|
407,8
|
458,5
|
Free Cash Flow
1 |
14.068
|
10.237
|
18.805
|
9.659
|
8.539
|
23.689
|
22.644
|
23.542
|
FCF-marge
|
12,26%
|
8,78%
|
15,43%
|
7,03%
|
5,92%
|
15,88%
|
14,76%
|
14,64%
|
Kasstroomconversie (ebitda)
|
58,47%
|
40,73%
|
63,35%
|
30,93%
|
24,33%
|
57,96%
|
54,93%
|
52,64%
|
Kasstroomconversie (nettowinst)
|
86,3%
|
60,7%
|
90,84%
|
38,66%
|
37,43%
|
86,51%
|
81,97%
|
75,83%
|
Dividend per aandeel
2 |
70,00
|
86,00
|
99,00
|
110,0
|
114,0
|
124,3
|
133,6
|
145,9
|
Datum van publicatie
|
13-05-19
|
13-05-20
|
14-05-21
|
11-05-22
|
11-05-23
|
-
|
-
|
-
|
Fiscaal tijdperk: Maart |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 S1
|
2026 S1
|
---|
Omzet
1 |
57.387
|
59.250
|
57.817
|
30.411
|
71.568
|
34.650
|
31.329
|
35.619
|
71.136
|
38.783
|
34.256
|
37.012
|
36.302
|
73.314
|
39.414
|
35.329
|
38.000
|
76.000
|
85.000
|
EBITDA
1 |
-
|
-
|
-
|
5.792
|
-
|
8.568
|
-293
|
-
|
-
|
10.117
|
3.424
|
-
|
-
|
-
|
10.805
|
7.228
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
11.025
|
10.643
|
11.140
|
5.056
|
21.504
|
7.817
|
-1.022
|
10.276
|
19.161
|
8.826
|
2.062
|
11.163
|
9.715
|
20.878
|
9.572
|
4.558
|
11.000
|
20.000
|
26.500
|
Operationele Marge
|
19,21%
|
17,96%
|
19,27%
|
16,63%
|
30,05%
|
22,56%
|
-3,26%
|
28,85%
|
26,94%
|
22,76%
|
6,02%
|
30,16%
|
26,76%
|
28,48%
|
24,29%
|
12,9%
|
28,95%
|
26,32%
|
31,18%
|
Resultaat voor belastingen (EBT)
1 |
11.271
|
11.171
|
11.248
|
5.652
|
22.250
|
8.313
|
-790
|
10.514
|
19.398
|
9.024
|
2.067
|
11.440
|
9.706
|
21.146
|
9.827
|
5.152
|
11.200
|
20.200
|
26.700
|
Nettowinst (verlies)
1 |
8.291
|
8.575
|
8.073
|
4.220
|
16.561
|
6.045
|
438
|
8.249
|
15.222
|
7.452
|
138
|
8.749
|
-
|
16.176
|
7.826
|
3.486
|
8.600
|
15.500
|
20.500
|
Nettomarge
|
14,45%
|
14,47%
|
13,96%
|
13,88%
|
23,14%
|
17,45%
|
1,4%
|
23,16%
|
21,4%
|
19,21%
|
0,4%
|
23,64%
|
-
|
22,06%
|
19,86%
|
9,87%
|
22,63%
|
20,39%
|
24,12%
|
WPA
2 |
123,1
|
-
|
119,9
|
62,65
|
245,9
|
89,75
|
6,500
|
122,5
|
226,0
|
110,6
|
2,050
|
129,9
|
-
|
240,2
|
116,2
|
37,05
|
127,7
|
230,1
|
304,4
|
Dividend per aandeel
2 |
43,00
|
-
|
49,00
|
-
|
51,00
|
-
|
-
|
-
|
57,00
|
-
|
-
|
-
|
62,00
|
62,00
|
-
|
60,00
|
-
|
-
|
-
|
Datum van publicatie
|
06-11-19
|
13-05-20
|
05-11-20
|
10-11-21
|
10-11-21
|
10-02-22
|
11-05-22
|
09-08-22
|
10-11-22
|
10-02-23
|
11-05-23
|
10-08-23
|
13-11-23
|
13-11-23
|
09-02-24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
42.138
|
47.114
|
60.799
|
57.853
|
68.937
|
74.297
|
92.487
|
111.474
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
14.068
|
10.237
|
18.805
|
9.659
|
8.539
|
23.689
|
22.644
|
23.542
|
ROE (netto-inkomsten/eigen vermogen)
|
12,5%
|
12%
|
13,5%
|
13,6%
|
12,1%
|
13,4%
|
12,5%
|
12,9%
|
ROA (netto-inkomsten/totale activa)
|
13,2%
|
13,1%
|
14,4%
|
16%
|
9,97%
|
11,9%
|
10%
|
10,3%
|
Totale activa
1 |
123.724
|
129.182
|
143.910
|
156.428
|
228.696
|
230.486
|
275.086
|
302.577
|
Nettoactief per aandeel
2 |
2.003
|
2.160
|
2.409
|
2.681
|
2.904
|
3.181
|
3.467
|
3.787
|
Cashflow per aandeel
2 |
293,0
|
302,0
|
360,0
|
439,0
|
414,0
|
496,0
|
488,0
|
539,0
|
Capex
1 |
1.242
|
2.500
|
2.583
|
10.744
|
5.660
|
9.000
|
8.600
|
9.385
|
Capex/omzet
|
1,08%
|
2,14%
|
2,12%
|
7,81%
|
3,93%
|
6,03%
|
5,61%
|
5,84%
|
Datum van publicatie
|
13-05-19
|
13-05-20
|
14-05-21
|
11-05-22
|
11-05-23
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
4.335
JPY Gemiddelde koersdoel
6.371
JPY Spread / Gemiddelde doel +46,98% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -13,23% | 1,85 mld. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|